Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home

This is the text extract for 3 Application form for Cancer Exceptional Circumstances, browse documents here.


Application Form for Cancer Exceptional Circumstances Approval

Return completed form to: Cancer Exceptional Circumstances Co-ordinator PHARMAC PO Box 10-254 Wellington Phone Fax: Email: 04-916-7553 09-523-6870 ecpanel@pharmac.govt.nz

(note: fax number redirects to Wgtn office)

Eligibility under Cancer Exceptional Circumstances Policy

A: Are you applying for approval to fund from the DHB budget, a pharmaceutical for the treatment of cancer that is not listed as a Pharmaceutical Cancer Treatment in Section B of the Pharmaceutical Schedule?

Yes

No

B: Has the proposed treatment been evaluated and approved using established DHB review mechanisms involving experienced clinicians?

Yes

No

C: Do you consider the situation for the proposed use to be unusual?

Yes

No

D: Is the total cost of this treatment less than $30,000? Note that applications in excess of $30,000 will be sent for a cost utility analysis and decision by PHARMAC (usual timeline 2-4 weeks).

Yes

No

E: Has the DHB that will be providing treatment agreed to provide funding? Please attach evidence if the DHB is other than that at which the applying specialist works.

Yes

No

If the answer to all of the above is yes, the proposed use may be eligible under the Cancer Exceptional Circumstances policy. Alternatively, the CEC or HEC policy should be used.

F: Is the proposed use under consideration by PHARMAC for funding, or has PHARMAC declined such use previously? (note a list of active applications for funding is available on PHARMAC’s website http://www.pharmac.govt.nz/pdf/090205.pdf – PHARMAC staff can assist in answering this question)

Yes

No

Don’t know

#89083

1


General Application Details

Please complete ALL relevant details. Please type or print CLEARLY.

Patient Details

Last Name: First Name: Address:

Details of Applying Practitioner

Last Name: First Name: Address:

Gender: Male/Female Date of Birth: NHI No: Phone No:

Phone: Facsimile: Email: NZMC#:

Disease/Condition

Attach further information if appropriate, a clinical report is

useful.

Medicine/treatment sought:

Complete fully, and attach additional information as necessary. To cover all strengths required.

Brand Name: Chemical Name: Manufacturer: Form and Strength: Cost per unit: Dosage to be used: Expected duration of treatment: Expected date of treatment initiation: Cost of treatment:

Frequency of condition or combination of clinical circumstances Please describe why the clinical circumstances requiring the proposed use are unusual, and an estimate of how often this circumstance occurs in NZ:

#89083

2


Pharmacy who will be supplying this product

Nominated Pharmacy (if approval given from where will supplies be obtained? This MUST be the hospital pharmacy that will be dispensing the product for the patient.)

Hospital: …………………………………………………………….………………………………. Address: ………………………………………………………….………………………………

…………………………………………………………………………………….

Phone:……………………………………Fax:…………………………………………………….

Other Issues Is there any other relevant information that should be considered?

Signature of Specialist: ______________________________________________________

Date of Request: ___________________________________________________________

#89083

3

Metadata

Title

3 Application form for Cancer Exceptional Circumstances

Abstract

Page 1

icon

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.